Abbott ADR Reporting Cited In FDA Warning Letter On Meridia, Norvir, Biaxin 

Abbott expects that continued improvements to its Adverse Event Global Information System (AEGIS) will address ADR reporting problems cited in an 1FDA warning letter

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet